FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

1255543000: Centrally acting antiobesity therapeutic role (role)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Oct 2022. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
5147347013 Centrally acting antiobesity therapeutic role (role) en Fully specified name Active Entire term case insensitive SNOMED CT core module
5147348015 Centrally acting antiobesity therapeutic role en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Centrally acting antiobesity therapeutic role Is a Antiobesity therapeutic role true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Medicinal product acting as centrally acting antiobesity agent (product) Plays role True Centrally acting antiobesity therapeutic role Inferred relationship Existential restriction modifier
Product containing phentermine in oral dose form (medicinal product form) Plays role True Centrally acting antiobesity therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely mazindol 1 milligram/1 each conventional release oral tablet Plays role True Centrally acting antiobesity therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely mazindol 2 milligram/1 each conventional release oral tablet Plays role True Centrally acting antiobesity therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely phentermine resin 15 milligram/1 each conventional release oral capsule Plays role True Centrally acting antiobesity therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely phentermine hydrochloride 30 milligram/1 each conventional release oral capsule Plays role True Centrally acting antiobesity therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely phentermine hydrochloride 18.75 milligram/1 each conventional release oral capsule Plays role True Centrally acting antiobesity therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely amfepramone hydrochloride 25 milligram/1 each conventional release oral tablet Plays role True Centrally acting antiobesity therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely phentermine hydrochloride 8 milligram/1 each conventional release oral tablet Plays role True Centrally acting antiobesity therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely phentermine hydrochloride 37.5 milligram/1 each conventional release oral tablet Plays role True Centrally acting antiobesity therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely phentermine hydrochloride 37.5 milligram/1 each conventional release oral capsule Plays role True Centrally acting antiobesity therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely phentermine resin 30 milligram/1 each conventional release oral capsule Plays role True Centrally acting antiobesity therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely phentermine hydrochloride 15 milligram/1 each conventional release oral capsule Plays role True Centrally acting antiobesity therapeutic role Inferred relationship Existential restriction modifier
Product containing amfepramone in oral dose form (medicinal product form) Plays role True Centrally acting antiobesity therapeutic role Inferred relationship Existential restriction modifier
Product containing mazindol in oral dose form (medicinal product form) Plays role True Centrally acting antiobesity therapeutic role Inferred relationship Existential restriction modifier
Product containing sibutramine in oral dose form (medicinal product form) Plays role True Centrally acting antiobesity therapeutic role Inferred relationship Existential restriction modifier
Diethylpropion Plays role True Centrally acting antiobesity therapeutic role Inferred relationship Existential restriction modifier
Naltrexone + Bupropion Plays role True Centrally acting antiobesity therapeutic role Inferred relationship Existential restriction modifier
Product containing bupropion and naltrexone Plays role True Centrally acting antiobesity therapeutic role Inferred relationship Existential restriction modifier
Product containing bupropion and naltrexone in oral dose form (medicinal product form) Plays role True Centrally acting antiobesity therapeutic role Inferred relationship Existential restriction modifier
Product containing dexfenfluramine Plays role True Centrally acting antiobesity therapeutic role Inferred relationship Existential restriction modifier
Product containing mazindol Plays role True Centrally acting antiobesity therapeutic role Inferred relationship Existential restriction modifier
Product containing phentermine Plays role True Centrally acting antiobesity therapeutic role Inferred relationship Existential restriction modifier
Product containing amfepramone Plays role True Centrally acting antiobesity therapeutic role Inferred relationship Existential restriction modifier
Product containing fenfluramine Plays role True Centrally acting antiobesity therapeutic role Inferred relationship Existential restriction modifier
Product containing sibutramine Plays role True Centrally acting antiobesity therapeutic role Inferred relationship Existential restriction modifier
Product containing only phentermine (medicinal product) Plays role True Centrally acting antiobesity therapeutic role Inferred relationship Existential restriction modifier
Sibutramine Plays role True Centrally acting antiobesity therapeutic role Inferred relationship Existential restriction modifier
Product containing only amfepramone in oral dose form (medicinal product form) Plays role True Centrally acting antiobesity therapeutic role Inferred relationship Existential restriction modifier
Product containing only bupropion and naltrexone in oral dose form (medicinal product form) Plays role True Centrally acting antiobesity therapeutic role Inferred relationship Existential restriction modifier
Product containing only mazindol in oral dose form (medicinal product form) Plays role True Centrally acting antiobesity therapeutic role Inferred relationship Existential restriction modifier
Product containing only phentermine in oral dose form (medicinal product form) Plays role True Centrally acting antiobesity therapeutic role Inferred relationship Existential restriction modifier
Product containing only sibutramine in oral dose form (medicinal product form) Plays role True Centrally acting antiobesity therapeutic role Inferred relationship Existential restriction modifier
Product containing only dexfenfluramine (medicinal product) Plays role True Centrally acting antiobesity therapeutic role Inferred relationship Existential restriction modifier
Fenfluramine Plays role True Centrally acting antiobesity therapeutic role Inferred relationship Existential restriction modifier
Mazindol Plays role True Centrally acting antiobesity therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely sibutramine hydrochloride 10 milligram/1 each conventional release oral capsule (clinical drug) Plays role True Centrally acting antiobesity therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely sibutramine hydrochloride 15 milligram/1 each conventional release oral capsule (clinical drug) Plays role True Centrally acting antiobesity therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely fenfluramine 2.2 milligram/1 milliliter conventional release oral solution (clinical drug) Plays role True Centrally acting antiobesity therapeutic role Inferred relationship Existential restriction modifier
Product containing fenfluramine in oral dose form (medicinal product form) Plays role True Centrally acting antiobesity therapeutic role Inferred relationship Existential restriction modifier
Product containing only fenfluramine in oral dose form (medicinal product form) Plays role True Centrally acting antiobesity therapeutic role Inferred relationship Existential restriction modifier
Product containing setmelanotide (medicinal product) Plays role True Centrally acting antiobesity therapeutic role Inferred relationship Existential restriction modifier
Product containing setmelanotide in parenteral dose form (medicinal product form) Plays role True Centrally acting antiobesity therapeutic role Inferred relationship Existential restriction modifier
Product containing only setmelanotide in parenteral dose form (medicinal product form) Plays role True Centrally acting antiobesity therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely setmelanotide (as setmelanotide acetate) 10 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Centrally acting antiobesity therapeutic role Inferred relationship Existential restriction modifier
Setmelanotide Plays role True Centrally acting antiobesity therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely sibutramine hydrochloride 5 milligram/1 each conventional release oral capsule (clinical drug) Plays role True Centrally acting antiobesity therapeutic role Inferred relationship Existential restriction modifier
Sibutramine 10mg capsules Plays role True Centrally acting antiobesity therapeutic role Inferred relationship Existential restriction modifier
Naltrexone 8mg / Bupropion 90mg modified-release tablets Plays role True Centrally acting antiobesity therapeutic role Inferred relationship Existential restriction modifier
Setmelanotide 10mg/1ml solution for injection vials Plays role True Centrally acting antiobesity therapeutic role Inferred relationship Existential restriction modifier
Fenfluramine 2.2mg/ml oral solution sugar free Plays role True Centrally acting antiobesity therapeutic role Inferred relationship Existential restriction modifier
Diethylpropion 75mg modified-release capsules Plays role True Centrally acting antiobesity therapeutic role Inferred relationship Existential restriction modifier
Sibutramine 15mg capsules Plays role True Centrally acting antiobesity therapeutic role Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start